Verdict Medical Devices

Perfuse announces Phase I/IIa trial data of intravitreal implant for glaucoma

Perfuse Therapeutics has reported 24-week data from its Phase I/IIa trial of the PER-001 intravitreal implant for individuals with glaucoma. The post Perfuse announces Phase I/IIa trial data of intravitreal implant for glaucoma appeared first on Medical Device Network.

Mar 4, 2025 - 17:41
 0
Perfuse announces Phase I/IIa trial data of intravitreal implant for glaucoma
Perfuse Therapeutics has reported 24-week data from its Phase I/IIa trial of the PER-001 intravitreal implant for individuals with glaucoma.

The post Perfuse announces Phase I/IIa trial data of intravitreal implant for glaucoma appeared first on Medical Device Network.

Read More

Tags:

Previous Article

Top Online Earning Strategies: How to Make Money from Anywhere

Next Article

ITB Berlin: Global Travel Market Continues Steady Growth Amid Challenges; AI Pre...

Related Posts

Teleflex to split into two separate entities

Teleflex to split into two separate entities

Feb 28, 2025  0

Apple UK update transforms AirPods into hearing aids

Apple UK update transforms AirPods into hearing aids

Feb 24, 2025  0

CereVasc scores safety and efficacy win in hydrocephalus treatment pilot study

CereVasc scores safety and efficacy win in hydrocephalu...

Feb 9, 2025  0